Astellas: Denmark Is the Perfect Location for our Nordic Headquarter  

2017.03.28

The global pharmaceutical company Astellas has gathered all corporate support functions to its Nordic and Baltic sales units in Denmark. This is owing to Denmark’s unique geography, allowing for a multicultural corporate environment with strong local understanding of all markets in the Nordic region.

The location in Copenhagen, the capital of Denmark, is popular among employees in the Nordic countries, since the Oresund Bridge makes the commute between Denmark and Sweden an easy ride both by train and car. Also, Copenhagen Airport has the most intercontinental, European, Scandinavian and Baltic connections of all the Scandinavian airports.

Strong local market understanding

This provides a clear commercial advantage for companies such as Astellas, providing services to the entire Nordic and Baltic region from its Nordic headquarters in Denmark.

“In Stockholm, 90 percent of our employees would be Swedish, in Oslo they would be Norwegian, and in Finland they would be Finns. But in Copenhagen, we have employees with four Nordic nationalities, with a majority of Danes and Swedes. This makes our work environment multicultural with a strong local market understanding of all our markets – which is important, because despite the global perception that the Nordic region is one homogeneous market, there are differences between the countries,” says Anders Nordén, General Manager Nordic & Baltic Operations, Astellas.

Astellas’ Nordic headquarters in Copenhagen has approximately 60 employees, supporting local sales offices in Denmark, Norway, Sweden, Iceland, Finland, Estonia, Latvia and Lithuania within administration, finance, HR, medical and marketing.

Medicon Valley offers a strong life science industry

In addition to the infrastructure with Copenhagen Airport and the Oresund Bridge, Copenhagen offers a very strong life science cluster in Medicon Valley.

“Medicon Valley is one of Europe’s leading life science clusters, providing easy access to many of the specialist skills, we need to employ. And with the Danish tax scheme for researchers and highly-paid employees, we have an attractive incentive to offer foreign candidates, who we want to attract,” says Anders Nordén.

“The life science industry in Denmark has developed into a strong and competitive cluster. Denmark offers a low corporate tax rate, competitive business costs, and flexible labour market conditions. Also, in Denmark there is a well-organised and publicly financed healthcare sector that maintains a high standard with highly qualified and motivated personnel, and Denmark offers some of the best possible conditions for conducting business in the life science industry,” explains Rasmus Beedholm-Ebsen, Ph.D., CBA and Special Advisor at Invest in Denmark.

How can we help you?

If you want to know more about Denmark’s life science industry or doing business in Denmark, please contact Rasmus Beedholm-Ebsen, Life Sciences Special Advisor, via phone +45 8993 5107 or e-mail rasbee@um.dk.

About Astellas

Astellas is one of the 20 largest pharmaceutical companies in the world with 17,500 employees worldwide, working to turn innovative science into value for patients. Prioritized therapeutic areas include urology, oncology, immunology, nephrology and neuroscience. In 2005, Astellas was founded through the merger of Yamanouchi and Fujisawa. With the Nordic office in Copenhagen, Astellas is represented in the whole Nordic region.

Next step

Explore business cases

Contact

Rasmus Beedholm-Ebsen

Rasmus Beedholm-Ebsen

+45 2856 8540

rasbee@um.dk

Contact

Niels Onteniente

Niels Onteniente

+33 6 0834 1776

nieont@um.dk

Contact

Rasmus Bjørnø

Rasmus Bjoernoe

+86 21 8025 0635

rasbjo@um.dk

Contact

Jannik Grodt Schmidt

Jannik Grodt Schmidt

+1 (212) 705 4955

jannsc@um.dk

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×